A (p)ppGpp-null mutant of Haemophilus ducreyi is partially attenuated in humans due to multiple conflicting phenotypes

Infection and Immunity

Volumn 82, Issue 8, 2014, Pages 3492-3502

  Holley, Concerta ^a   Gangaiah, Dharanesh ^a   Li, Wei ^a   Fortney, Kate R ^a   Janowicz, Diane M ^a   Ellinger, Sheila ^a   Zwickl, Beth ^a   Katz, Barry P ^a   Spinola, Stanley M ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; DKSA PROTEIN; TRANSCRIPTION FACTOR LSPB; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR SPOT; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CLINICAL ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GENE CONSTRUCT; GENE CONTROL; HAEMOPHILUS DUCREYI; HUMAN; HUMAN CELL; MACROPHAGE; MALE; NULL ALLELE; OXIDATIVE STRESS; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SURVIVAL TIME; ULCUS MOLLE; VOLUNTEER;

ADULT; DERMATITIS; FEMALE; GENE DELETION; GENETIC COMPLEMENTATION TEST; GUANOSINE PENTAPHOSPHATE; HAEMOPHILUS DUCREYI; HEALTHY VOLUNTEERS; HUMANS; LIGASES; MALE; MIDDLE AGED; PYROPHOSPHATASES;

EID: 84904724476     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01994-14     Document Type: Article

References (66)

1. Spinola SM. 2008. Chancroid and Haemophilus ducreyi, p 689-699. In Holmes KK, Sparling PF, Stamm WE, Piot P, Wasserheit JN, Corey L, Cohen MS, Watts DH (ed), Sexually transmitted diseases, 4th ed. McGraw-Hill, New York, NY.
2. Steen R, Wi TE, Kamali A, Ndowa F. 2009. Control of sexually transmitted infections and prevention of HIV transmission: mending a fractured paradigm. Bull. World Health Organ. 87:858-865. http://dx.doi .org/10.2471/BLT.08.059212.
3. Phiri S, Zadrozny S, Weiss HA, Martinson F, Nyirenda N, Chen CY, Miller WC, Cohen MS, Mayaud P, Hoffman IF. 2013. Etiology of genital ulcer disease and association with HIV infection in Malawi. Sex. Transm. Dis. 40:923-928. http://dx.doi.org/10.1097/OLQ.0000000000000051.
4. Fayemiwo SA, Odaibo GN, Oni AA, Ajayi AA, Bakare RA, Olaleye DO. 2011. Genital ulcer diseases among HIV-infected female commercial sex workers in Ibadan, Nigeria. Afr. J. Med. Med. Sci. 40:39-46.
5. Maan MA, Hussain F, Iqbal J, Akhtar SJ. 2011. Sexually transmitted infections in Pakistan. Ann. Saudi Med. 31:263-269. http://dx.doi.org/10 .4103/0256-4947.81541.
6. Bhutto AM, Shah AH, Ahuja DK, Solangi AH, Shah SA. 2011. Pattern of sexually transmitted infections in males in interior Sindh: a 10-yearstudy. J. Ayub Med. Coll. Abbottabad 23:110-114.
7. Weiss HA, Paz Bailey G, Phiri S, Gresenguet G, LeGoff J, Pepin J, Lewis DA, Belec L, Hoffman IF, Miller WC, Mayaud P. 2011. Episodic therapy for genital herpes in sub-Saharan Africa: a pooled analysis from three randomized controlled trials. PLoS One 6:e22601. http://dx.doi.org/10 .1371/journal.pone.0022601.
8. Ray K, Bala M, Gupta SM, Khunger N, Puri P, Muralidhar S, Kumar J. 2006. Changing trends in sexually transmitted infections at a regional STD Centre in north India. Indian J. Med. Res. 124:559-568.
9. Mitjà O, Lukehart SA, Pokowas G, Moses P, Kapa A, Godornes C, Robson J, Cherian S, Houinei W, Kazadi W, Siba P, de Lazzari E, Bassat Q. 2014. Haemophilus ducreyi as a cause of skin ulcers in children from a yaws-endemic area of Papua New Guinea: a prospective cohort study. Lancet Glob. Health 2:e235- e241. http://dx.doi.org/10.1016/S2214 -109X(14)70019-1.
10. Marckmann P, Hojbjerg T, von Eyben FE, Christensen I. 1989. Imported pedal chancroid: case report. Genitourin. Med. 65:126-127.
11. Ussher JE, Wilson E, Campanella S, Taylor SL, Roberts SA. 2007. Haemophilus ducreyi causing chronic skin ulceration in children visiting Samoa. Clin. Infect. Dis. 44:e85- e87. http://dx.doi.org/10.1086/515404.
12. McBride WJ, Hannah RC, Le Cornec GM, Bletchly C. 2008. Cutaneous chancroid in a visitor from Vanuatu. Australas. J. Dermatol. 49:98-99. http://dx.doi.org/10.1111/j.1440-0960.2008.00439.x.
13. Peel TN, Bhatti D, De Boer JC, Stratov I, Spelman DW. 2010. Chronic cutaneous ulcers secondary to Haemophilus ducreyi infection. Med. J. Aust. 192:348-350.
14. Schmid GP. 1999. Treatment of chancroid, 1997. Clin. Infect. Dis. 28(Suppl 1):S14 -S20. http://dx.doi.org/10.1086/514727.
15. Tyndall M, Malisa M, Plummer FA, Ombetti J, Ndinya-Achola JO, Ronald AR. 1993. Ceftriaxone no longer predictably cures chancroid in Kenya. J. Infect. Dis. 167:469-471. http://dx.doi.org/10.1093/infdis/167.2 .469.
16. Knapp JS, Back AF, Babst AF, Taylor D, Rice RJ. 1993. In vitro susceptibilities of isolates of Haemophilus ducreyi from Thailand and the United States to currently recommended and newer agents for treatment of chancroid. Antimicrob. Agents Chemother. 37:1552-1555. http://dx.doi.org /10.1128/AAC.37.7.1552.
17. Janowicz DM, Ofner S, Katz BP, Spinola SM. 2009. Experimental infection of human volunteers with Haemophilus ducreyi: fifteen years of clinical data and experience. J. Infect. Dis. 199:1671-1679. http://dx.doi .org/10.1086/598966.
18. Bauer ME, Goheen MP, Townsend CA, Spinola SM. 2001. Haemophilus ducreyi associates with phagocytes, collagen, and fibrin and remains extracellular throughout infection of human volunteers. Infect. Immun. 69: 2549-2557. http://dx.doi.org/10.1128/IAI.69.4.2549-2557.2001.
19. 2, pH, and redox potential of experimental abscesses. Proc. Soc. Exp. Biol. Med. 147:29-30. http://dx.doi.org/10 .3181/00379727-147-38275.
20. Labandeira-Rey M, Dodd D, Fortney KR, Zwickl B, Katz BP, Janowicz DM, Spinola SM, Hansen EJ. 2011. A Haemophilus ducreyi cpxR deletion mutant is virulent in human volunteers. J. Infect. Dis. 203:1859-1865. http://dx.doi.org/10.1093/infdis/jir190.
21. Bauer ME, Fortney KR, Harrison A, Janowicz DM, Munson RS, Jr, Spinola SM. 2008. Identification of Haemophilus ducreyi genes expressed during human infection. Microbiology 154:1152-1160. http://dx.doi.org /10.1099/mic.0.2007/013953-0.
22. Gentry DR, Cashel M. 1996. Mutational analysis of the Escherichia coli spoT gene identifies distinct but overlapping regions involved in ppGpp synthesis and degradation. Mol. Microbiol. 19:1373-1384. http://dx.doi .org/10.1111/j.1365-2958.1996.tb02480.x.
23. Chatterji D, Ojha AK. 2001. Revisiting the stringent response, ppGpp and starvation signaling. Curr. Opin. Microbiol. 4:160-165. http://dx.doi.org /10.1016/S1369-5274(00)00182-X.
24. Vinella D, Albrecht C, Cashel M, D'Ari R. 2005. Iron limitation induces SpoT-dependent accumulation of ppGpp in Escherichia coli. Mol. Microbiol. 56:958-970. http://dx.doi.org/10.1111/j.1365-2958.2005.04601.x.
25. Dalebroux ZD, Edwards RL, Swanson MS. 2009. SpoT governs Legionella pneumophila differentiation in host macrophages. Mol. Microbiol. 71:640-658. http://dx.doi.org/10.1111/j.1365-2958.2008.06555.x.
26. Na HS, Kim HJ, Lee HC, Hong Y, Rhee JH, Choy HE. 2006. Immune response induced by Salmonella typhimurium defective in ppGpp synthesis. Vaccine 24:2027-2034. http://dx.doi.org/10.1016/j.vaccine.2005.11 .031.
27. Sun W, Roland KL, Branger CG, Kuang X, Curtiss R, III. 2009. The role of relA and spoT in Yersinia pestis KIM5 pathogenicity. PLoS One 4:e6720. http://dx.doi.org/10.1371/journal.pone.0006720.
28. Bugrysheva JV, Bryksin AV, Godfrey HP, Cabello FC. 2005. Borrelia burgdorferi rel is responsible for generation of guanosine-3=-diphosphate-5=-triphosphate and growth control. Infect. Immun. 73:4972-4981. http: //dx.doi.org/10.1128/IAI.73.8.4972-4981.2005.
29. Geiger T, Goerke C, Fritz M, Schafer T, Ohlsen K, Liebeke M, Lalk M, Wolz C. 2010. Role of the (p) ppGpp synthase RSH, a RelA/SpoT homolog, in stringent response and virulence of Staphylococcus aureus. Infect. Immun. 78:1873-1883. http://dx.doi.org/10.1128/IAI.01439-09.
30. Vogt SL, Green C, Stevens KM, Day B, Erickson DL, Woods DE, Storey DG. 2011. The stringent response is essential for Pseudomonas aeruginosa virulence in the rat lung agar bead and Drosophila melanogaster feeding models of infection. Infect. Immun. 79:4094-4104. http://dx.doi.org/10 .1128/IAI.00193-11.
31. Dahl JL, Kraus CN, Boshoff HI, Doan B, Foley K, Avarbock D, Kaplan G, Mizrahi V, Rubin H, Barry CE, III. 2003. The role of RelMtbmediated adaptation to stationary phase in long-term persistence of Mycobacterium tuberculosis in mice. Proc. Natl. Acad. Sci. U. S. A. 100:10026- 10031. http://dx.doi.org/10.1073/pnas.1631248100.
32. Abranches J, Martinez AR, Kajfasz JK, Chavez V, Garsin DA, Lemos JA. 2009. The molecular alarmone (p)ppGpp mediates stress responses, vancomycin tolerance, and virulence in Enterococcus faecalis. J. Bacteriol. 191: 2248-2256. http://dx.doi.org/10.1128/JB.01726-08.
33. Bozue JA, Tarantino L, Munson RS, Jr. 1998. Facile construction of mutations in Haemophilus ducreyi using lacz as a counter-selectable marker. FEMS Microbiol. Lett. 164:269-273. http://dx.doi.org/10.1111/j .1574-6968.1998.tb13097.x.
34. Labandeira-Rey M, Brautigam CA, Hansen EJ. 2010. Characterization of the CpxRA regulon in Haemophilus ducreyi. Infect. Immun. 78:4779- 4791. http://dx.doi.org/10.1128/IAI.00678-10.
35. Xiao H, Kalman M, Ikehara K, Zemel S, Glaser G, Cashel M. 1991. Residual guanosine 3',5'-bispyrophosphate synthetic activity of relA null mutants can be eliminated by spoT null mutations. J. Biol. Chem. 266: 5980-5990.
36. Gibson DG, Young L, Chuang RY, Venter JC, Hutchison CA, III, Smith HO. 2009. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat. Methods 6:343-345. http://dx.doi.org/10.1038/nmeth .1318.
37. Spinola SM, Fortney KR, Katz BP, Latimer JL, Mock JR, Vakevainen M, Hansen EJ. 2003. Haemophilus ducreyi requires an intact flp gene cluster for virulence in humans. Infect. Immun. 71:7178-7182. http://dx.doi.org /10.1128/IAI.71.12.7178-7182.2003.
38. Concepcion MB, Nelson DR. 2003. Expression of spoT in Borrelia burgdorferi during serum starvation. J. Bacteriol. 185:444-452. http://dx.doi .org/10.1128/JB.185.2.444-452.2003.
39. Gangaiah D, Liu Z, Arcos J, Kassem II, Sanad Y, Torrelles JB, Rajashekara G. 2010. Polyphosphate kinase 2: a novel determinant of stress responses and pathogenesis in Campylobacter jejuni. PLoS One 5:e12142. http://dx.doi.org/10.1371/journal.pone.0012142.
40. Apicella MA, Griffiss JM, Schneider H. 1994. Isolation and characterization of lipopolysaccharides, lipooligosaccharides, and lipid A. Methods Enzymol. 235:242-252. http://dx.doi.org/10.1016/0076-6879(94)35145-7.
41. Spinola SM, Griffiths GE, Bogdan JA, Menegus MA. 1992. Characterization of an 18,000-molecular-weight outer membrane protein of Haemophilus ducreyi that contains a conserved surface-exposed epitope. Infect. Immun. 60:385-391.
42. Spinola SM, Fortney KR, Baker B, Janowicz DM, Zwickl B, Katz BP, Blick RJ, Munson RS, Jr. 2010. Activation of the CpxRA system by deletion of cpxA impairs the ability of Haemophilus ducreyi to infect humans. Infect. Immun. 78:3898 -3904. http://dx.doi.org/10.1128/IAI .00432-10.
43. Prather DT, Bains M, Handcock REW, Filiatrault MJ, Campagnari AA. 2004. Differential expression of porins OmpP2A and OmpP2B of Haemophilus ducreyi. Infect. Immun. 72:6271-6278. http://dx.doi.org/10.1128 /IAI.72.11.6271-6278.2004.
44. Elkins C, Morrow KJ, Olsen B. 2000. Serum resistance in Haemophilus ducreyi requires outer membrane protein DsrA. Infect. Immun. 68:1608- 1619. http://dx.doi.org/10.1128/IAI.68.3.1608-1619.2000.
45. White CD, Leduc I, Jeter C, Harris C, Elkins C. 2005. Haemophilus ducreyi outer membrane determinants, including DsrA, define two clonal populations. Infect. Immun. 73:2387-2399. http://dx.doi.org/10.1128 /IAI.73.4.2387-2399.2005.
46. Gangaiah D, Li W, Fortney KR, Janowicz DM, Ellinger S, Zwickl B, Katz BP, Spinola SM. 2013. Carbon storage regulator A contributes to the virulence of Haemophilus ducreyi in humans by multiple mechanisms. Infect. Immun. 81:608-617. http://dx.doi.org/10.1128/IAI.01239-12.
47. Young RS, Fortney K, Haley JC, Hood AF, Campagnari AA, Wang J, Bozue JA, Munson RSJ, Spinola SM. 1999. Expression of sialylated or paragloboside-like lipooligosaccharides are not required for pustule formation by Haemophilus ducreyi in human volunteers. Infect. Immun. 67: 6335-6340.
48. Tobe T, Kusukawa N, Yura T. 1987. Suppression of rpoH (htpR) mutations of Escherichia coli: heat shock response in suhA revertants. J. Bacteriol. 169:4128-4134.
49. Wang QP, Kaguni JM. 1989. A novel sigma factor is involved in expression of the rpoH gene of Escherichia coli. J. Bacteriol. 171:4248-4253.
50. Traxler MF, Summers SM, Nguyen HT, Zacharia VM, Hightower GA, Smith JT, Conway T. 2008. The global, ppGpp-mediated stringent response to amino acid starvation in Escherichia coli. Mol. Microbiol. 68: 1128-1148. http://dx.doi.org/10.1111/j.1365-2958.2008.06229.x.
51. Sturm AW, Zanen HC. 1984. Characteristics of Haemophilus ducreyi in culture. J. Clin. Microbiol. 19:672-674.
52. Bauer ME, Spinola SM. 2000. Localization of Haemophilus ducreyi at the pustular stage of disease in the human model of infection. Infect. Immun. 68:2309-2314. http://dx.doi.org/10.1128/IAI.68.4.2309-2314.2000.
53. Vakevainen M, Greenberg S, Hansen EJ. 2003. Inhibition of phagocytosis by Haemophilus ducreyi requires expression of the LspA1 and LspA2 proteins. Infect. Immun. 71:5994-6003. http://dx.doi.org/10.1128/IAI.71 .10.5994-6003.2003.
54. Ward CK, Mock JR, Hansen EJ. 2004. The LspB protein is involved in the secretion of the LspA1 and LspA2 proteins by Haemophilus ducreyi. Infect. Immun. 72:1874 -1884. http://dx.doi.org/10.1128/IAI.72.4.1874-1884 .2004.
55. Khakimova M, Ahlgren HG, Harrison JJ, English AM, Nguyen D. 2013. The stringent response controls catalases in Pseudomonas aeruginosa and is required for hydrogen peroxide and antibiotic tolerance. J. Bacteriol. 195:2011-2020. http://dx.doi.org/10.1128/JB.02061-12.
56. Yan X, Zhao C, Budin-Verneuil A, Hartke A, Rince A, Gilmore MS, Auffray Y, Pichereau V. 2009. The (p)ppGpp synthetase RelA contributes to stress adaptation and virulence in Enterococcus faecalis V583. Microbiology 155:3226-3237. http://dx.doi.org/10.1099/mic.0.026146-0.
57. Perederina A, Svetlov V, Vassylyeva MN, Tahirov TH, Yokoyama S, Artsimovitch I, Vassylyev DG. 2004. Regulation through the secondary channel-structural framework for ppGpp-DksA synergism during transcription. Cell 118:297-309. http://dx.doi.org/10.1016/j.cell.2004.06.030.
58. Potrykus K, Cashel M. 2008. (p)ppGpp: still magical? Annu. Rev. Microbiol. 62:35-51. http://dx.doi.org/10.1146/annurev.micro.62 .081307.162903.
59. Geiger T, Kastle B, Gratani FL, Goerke C, Wolz C. 2014. Two small (p)ppGpp synthases in Staphylococcus aureus mediate tolerance against cell envelope stress conditions. J. Bacteriol. 196:894-902. http://dx.doi .org/10.1128/JB.01201-13.
60. Gaca AO, Kajfasz JK, Miller JH, Liu K, Wang JD, Abranches J, Lemos JA. 2013. Basal levels of (p)ppGpp in Enterococcus faecalis: the magic beyond the stringent response. mBio 4:e00646-13. http://dx.doi.org/10.1128 /mBio.00646-13.
61. Bauer ME, Townsend CA, Ronald AR, Spinola SM. 2006. Localization of Haemophilus ducreyi in naturally acquired chancroidal ulcers. Microbes Infect. 8:2465-2468. http://dx.doi.org/10.1016/j.micinf.2006.06.001.
62. Janowicz D, Luke NR, Fortney KR, Katz BP, Campagnari AA, Spinola SM. 2006. Expression of OmpP2A and OmpP2B is not required for pustule formation by Haemophilus ducreyi in human volunteers. Microb. Pathog. 40:110-115. http://dx.doi.org/10.1016/j.micpath.2005.11.005.
63. Magnusson LU, Gummesson B, Joksimovic P, Farewell A, Nystrom T. 2007. Identical, independent, and opposing roles of ppGpp and DksA in Escherichia coli. J. Bacteriol. 189:5193-5202. http://dx.doi.org/10.1128/JB .00330-07.
64. Lee EC, Yu D, Martinez de Velasco J, Tessarollo L, Swing DA, Court DL, Jenkins NA, Copeland NG. 2001. A highly efficient Escherichia colibased chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 73:56-65. http://dx.doi .org/10.1006/geno.2000.6451.
65. Al-Tawfiq JA, Thornton AC, Katz BP, Fortney KR, Todd KD, Hood AF, Spinola SM. 1998. Standardization of the experimental model of Haemophilus ducreyi infection in human subjects. J. Infect. Dis. 178:1684-1687. http://dx.doi.org/10.1086/314483.
66. Tracy E, Ye F, Baker BD, Munson RS, Jr. 2008. Construction of nonpolar mutants in Haemophilus influenzae using FLP recombinase technology. BMC Mol. Biol. 9:101. http://dx.doi.org/10.1186/1471-2199-9-101.